key: cord-0709856-p1hytht9 authors: Ding, Yanna; L Steed, Lisa; Batalis, Nicholas title: First Reported Case of Disseminated Microascus gracilis Infection in a Lung Transplant Patient date: 2020-10-06 journal: IDCases DOI: 10.1016/j.idcr.2020.e00984 sha: 7dce83a1982da23047480f44dee314115c6cc358 doc_id: 709856 cord_uid: p1hytht9 Microascus gracilis is a specie of the genus Microascus in the family of Microascaceae and has been isolated from lung. It has never been reported as the cause of disseminated infection in humans. Herein, we report a fatal case of disseminated Microascus gracilis infection in a 65-year-old man with a history of primary idiopathic pulmonary fibrosis, status-post bilateral lung transplant. His course was complicated by donor lung cultures positive for multiple organisms and persistent pleural effusions. Multiple lung biopsy and bronchial lavage specimens were negative for mold. Later, pleural fluid cultures grew M. gracilis confirmed by DNA sequencing. Despite aggressive antifungal treatment, the patient continued to deteriorate with altered mental status. Imaging showed scattered hemorrhagic and hypodense lesions in the brain. The patient eventually succumbed to his infections and a restricted autopsy was performed. Autopsy findings included multiple hemorrhagic foci and abscesses involving the whole brain. Numerous punctuate, tan-white circular lesions were on the endocardium and diffuse tan exudates covered the pericardium and lungs. Histologically, similar fungal organisms with septate branching hyphae and short chains of conidia were identified, along with hemorrhage, neutrophilic inflammation, and necrosis in the brain, pleura, peripheral parenchyma of lungs and heart. This is the first reported case of disseminated M. gracilis infection in an immunosuppressed human, indicating it can cause localized infections and disseminated infections. This case increases our awareness of such fatal opportunistic infections, particularly in lung transplant patients, and urges earlier aggressive prophylaxis, diagnosis, and treatment. opportunistic infections, particularly in lung transplant patients, and urges earlier aggressive prophylaxis, diagnosis, and treatment. Keywords: Microascus gracilis, Scopulariopsis gracilis, disseminated infection, lung transplant Introduction: Solid organ transplantation has become more and more sophisticated in technique, and is anticipated to increase over time, yet fungal infections leading to high morbidity and mortality remain threatening. Organisms in the genera Microascus and Scopulariopsis of the family Microascaceae are common hyaline molds that cause hyalohyphomycosis and are frequently discussed together regarding rare but severe opportunistic infections in transplant patients. Species of these two genera are usually found in soil, decaying plant material, indoor environments, and even food [1, 2] , and have been involved in superficial infections as well as localized invasive infections, including cutaneous and brain abscesses, invasive sinusitis and endocarditis [3] [4] [5] [6] [7] [8] . Recently, the taxonomy of the Microascaceae was reevaluated based on DNA sequencing for four loci ---internal transcribed spacer (ITS), a fragment including the D1/D2 regions of the LSU rDNA gene, fragments of the translation elongation factor 1-alpha (EF-1α), and the beta-tubulin gene (TUB) [1] . Scopulariopsis gracilis was re-categorized and designated as Microascus gracilis [1] . M. gracilis has been isolated from human bronchoalveolar lavage (BAL) fluid, synovial fluid, and sputum samples [1, 9] and was recently reported to cause localized bronchopulmonary infection in a lung transplant patient [10] . We report a fatal case of disseminated infection of M. gracilis in a lung transplant patient, followed by a literature review on documented infections by Microascus spp in solid organ transplant patients. A 65-year-old man with a history of primary idiopathic pulmonary fibrosis underwent lung transplantation organisms. However, a brain CT and magnetic resonance imaging (MRI) scan showed scattered hemorrhagic, ischemic, hypodense, and nodular foci involving the brain, raising clinical concern about disseminated fungal infection. Since echinocandins poorly penetrate the brain, isavuconazonium sulfate (372 mg, IV, three times per 24 hours), amphotericin B (500mg, IV, once per 24 hours), and terbinafine (250 mg, per nasogastric tube, once daily) were added to micafungin (day 118). The patient then also presented with potential bilateral fungal endophthalmitis and became unresponsive (day 124). Due to declining clinical status, care was withdrawn and an autopsy was ordered. On D131, drug susceptibility testing performed by the Fungus Testing Laboratory indicated that minimal inhibitory concentrations (MICs) were 1 mcg/ml for amphotericin B, >16 mcg/ml for both posaconazole and voriconazole, 2 mcg/ml for isavuconazole, and 2 mcg/ml for terbinafine and the minimum effective concentration (MEC) was 1 mcg/ml for micafungin. External autopsy findings included multiple skin ulcerations, right sternal wound dehiscence, and ecchymosis around the eyes. Internal exam showed multiple hemorrhagic foci and abscesses involving the cerebral hemispheres from the frontal lobes to occipital lobes, basal ganglia, midbrain, brainstem, and right cerebellum (Figure 1. A and B) . The left ventricle was filled with hemorrhagic and necrotic material. Portions of the brain tissue were submitted for fungal culture which showed growth of M. gracilis. (Figure 3 ). Numerous punctuate tan-white circular lesions up to 0.3 cm were on the endocardium and a tan exudate and adhesion were on the pericardium. There were 200 ml of red-tan fluid in the left pleural cavity and the pleural surfaces were covered by tan-yellow exudates (Figure 1 . C). The pulmonary parenchyma was dark red-purple with increased edema and a rubbery texture and the interlobular septa were covered with tan-yellow exudates (Figure 1. D) . On histological examination, sections of the brain demonstrated scattered necrotic foci with fungal organisms, numerous neutrophils, and hemorrhage, consistent with abscess formation. Parenchymal edema, congestion, perivascular inflammatory infiltrates, and hemorrhage were also present. Similar changes were found through the cerebral hemispheres, basal ganglia, mid brain, and cerebellum. The terbinafine achieves the highest rate of synergistic effect, followed by amphotericin B plus caspofungin, posaconazole plus caspofungin, and voriconazole plus caspofungin [18] . In fact, as shown in Table 1 for Microascus spp, the combination of posaconazole plus terbinafine (with amphotericin B and/or micafungin) cured two of the three infections, while the combination of voriconazole, terbinafine, amphotericin B, and caspofungin was effective in the third case [10, 11, 15] . Therefore, for multidrug Furthermore, once the fungal isolation is determined to be an invasive infection or taken as true infection, expedited fungus identification and susceptibility testing is another challenging but critical step for prompt and appropriate clinical management. As solid organ transplantation continues to increase, opportunistic infections by rare pathogens like Microascus spp will become more common. Hopefully, this case increases our awareness of such opportunistic infections, particularly in lung transplant patients, and urges earlier aggressive prophylaxis, diagnosis, and treatment. Disclosure of grants or other funding: Nothing to declare Conflict of Interest statement: All authors declare that there is no conflict of interest All authors read the revised manuscript and accepted all the changes to the original manuscript. Yanna Ding collected and analyzed data, wrote and revised the manuscript. Lisa L Steed and Nicholas Batalis analyzed the data and revised the manuscript. This is a case report on an autopsy case using unidentified gross organ pictures, histopathology pictures and fungal culture pictures. The case description in the paper is also deidentified. The deceased's family is not contactable. Yanna Ding collected and analyzed data, wrote and revised the manuscript. Lisa L Steed and Nicholas Batalis analyzed the data and revised the manuscript Redefining Microascus, Scopulariopsis and allied genera Scopulariopsis and scopulariopsis-like species from indoor environments Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient Invasive sinonasal disease due to Scopulariopsis candida: case report and review of scopulariopsosis Deep tissue infections caused by Scopulariopsis brevicaulis: report of a case of prosthetic valve endocarditis and review Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia Scopulariopsis brevicaulis infection of prosthetic valve resembling aspergilloma on histopathology Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs Scopulariopsis/Microascus isolation in lung transplant recipients: A report of three cases and a review of the literature Necrotizing Microascus tracheobronchitis in a bilateral lung transplant recipient Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient Successful eradication of invasive Scopulariopsis brumptii in a liver transplant recipient Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents Antifungal susceptibilities of the species of the Pseudallescheria boydii complex In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis None Nothing to declare